Ignite Creation Date:
2024-05-05 @ 9:57 PM
Last Modification Date:
2024-10-26 @ 10:11 AM
Study NCT ID:
NCT00991146
Status:
COMPLETED
Last Update Posted:
2020-09-25
First Post:
2009-10-06
Brief Title:
Efficacy and Safety Study of Canakinumab Administered for 6 Months 24 Weeks in Japanese Patients With Cryopyrin-associated Periodic Syndromes Followed by an Extension Phase
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Organization Data
Organization:
Novartis
Class:
INDUSTRY
Study ID:
CACZ885D2308
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Novartis Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None